Alpha 2.0
Login Register
» Articles » PMID: 32815513

Case Report: COVID-19 Recovery from Triple Infection with , HIV, and SARS-CoV-2

Overview
Journal Am J Trop Med Hyg
Specialty Tropical Medicine
Date 2020 Aug 21
PMID 32815513
Citations 22
Authors
Neyla Rivas
Mario Espinoza
Alejandra Loban
Odemaris Luque
Julio Jurado
Nicolas Henry-Hurtado
Amador Goodridge
Affiliations
Soon will be listed here.
Abstract

COVID-19, designated as SARS-CoV-2, has caused millions of infections worldwide, including in patients with concomitant infections. Here, we report two unusual cases of patients with triple infections of SARS-CoV-2, , and HIV. Both cases were confirmed through microbiological and immunological studies. The acute respiratory phase in both patients was treated with supplemental oxygen. Antituberculosis and antiretroviral therapies were started simultaneously. In 2 weeks, both patients demonstrated clinical improvement and recovery from COVID-19. Our findings suggest that even in cases of triple infection, clinical management together with respiratory therapy contributes to patient survival.

Citing Articles

Clinical epidemiological and laboratory investigation in co-infection with COVID-19 and tuberculosis.

Belchior A, Freitas Neto A, Gusmao G, Santos E, Ferreira Lemos E, Pompilio M Rev Inst Med Trop Sao Paulo. 2024; 66:e65.

PMID: 39536219 PMC: 11556834. DOI: 10.1590/S1678-9946202466065.

Drug-Resistant TB, HIV and COVID-19 Co-Infection: Case Reviews from Kwa-Zulu Natal, South Africa.

Hassan-Moosa R, Motsomi K, Narasimmulu R, Sivro A, Naidu K, Kharsany A Infect Drug Resist. 2023; 16:7663-7670.

PMID: 38126006 PMC: 10731725. DOI: 10.2147/IDR.S433695.

Superimposed Pulmonary Tuberculosis (PTB) in a 26-Year-Old Female with No Underlying Co-Morbidities Recovering from COVID-19-Case Report.

Njekwa K, Muyoyeta M, Mulenga B, Chisenga C, Simuyandi M, Chilengi R Trop Med Infect Dis. 2023; 8(5).

PMID: 37235316 PMC: 10221239. DOI: 10.3390/tropicalmed8050268.

COVID-19 and tuberculosis coinfection: An overview of case reports/case series and meta-analysis of prevalence studies.

Daneshvar P, Hajikhani B, Sameni F, Noorisepehr N, Zare F, Bostanshirin N Heliyon. 2023; 9(2):e13637.

PMID: 36789387 PMC: 9911156. DOI: 10.1016/j.heliyon.2023.e13637.

Clinical Outcomes of Individuals with COVID-19 and Tuberculosis during the Pre-Vaccination Period of the Pandemic: A Systematic Review.

Jhaveri T, Fung C, LaHood A, Lindeborg A, Zeng C, Rahman R J Clin Med. 2022; 11(19).

PMID: 36233523 PMC: 9570663. DOI: 10.3390/jcm11195656.

References
1.
Ong C, Migliori G, Raviglione M, Macgregor-Skinner G, Sotgiu G, Alffenaar J . Epidemic and pandemic viral infections: impact on tuberculosis and the lung: A consensus by the World Association for Infectious Diseases and Immunological Disorders (WAidid), Global Tuberculosis Network (GTN), and members of the European Society of.... Eur Respir J. 2020; 56(4). PMC: 7527651. DOI: 10.1183/13993003.01727-2020. View
2.
Moreno R, Ravasi G, Avedillo P, Lopez R . Tuberculosis and HIV coinfection and related collaborative activities in Latin America and the Caribbean. Rev Panam Salud Publica. 2020; 44:e43. PMC: 7236861. DOI: 10.26633/RPSP.2020.43. View
3.
Vizcarra P, Perez-Elias M, Quereda C, Moreno A, Vivancos M, Dronda F . Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort. Lancet HIV. 2020; 7(8):e554-e564. PMC: 7255735. DOI: 10.1016/S2352-3018(20)30164-8. View
4.
Gervasoni C, Meraviglia P, Riva A, Giacomelli A, Oreni L, Minisci D . Clinical Features and Outcomes of Patients With Human Immunodeficiency Virus With COVID-19. Clin Infect Dis. 2020; 71(16):2276-2278. PMC: 7239244. DOI: 10.1093/cid/ciaa579. View
5.
Tadolini M, Codecasa L, Garcia-Garcia J, Blanc F, Borisov S, Alffenaar J . Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases. Eur Respir J. 2020; 56(1). PMC: 7251245. DOI: 10.1183/13993003.01398-2020. View